Literature DB >> 12046076

Reduction of the incidence and mortality of rectal cancer by polypectomy: a prospective cohort study in Haining County.

Shu Zheng1, Xi-Yong Liu, Ke-Feng Ding, Lin-Bo Wang, Pei-Lin Qiu, Xin-Feng Ding, Yong-Zhou Shen, Gao-Fei Shen, Qi-Rong Sun, Wei-Dong Li, Qi Dong, Su-Zhan Zhang.   

Abstract

AIM: To reduce the incidence and mortality of rectal cancer and address the hypothesis that colorectal cancer often arise from precursor lesion(s), either adenomas or non-adenomatous polyps, by conducting a population-based mass screening for colorectal cancer in Haining County, Zhejiang, PRC.
METHODS: From 1977 to 1980, physicians screened the population of Haining County using 15 cm rigid endoscopy. Of over 240000 participants, 4076 of them were diagnosed with precursor lesions, either adenomas or non-adenomatous polyps, which were then removed surgically. All individuals with precursor lesions were followed up and reexamined by endoscopy every two to five years up to 1998.
RESULTS: After the initial screening, 953 metachronous adenomas and 417 non-adenomatous polyps were detected and removed from the members of this cohort. Further, 27 cases of colorectal cancer were detected and treated. Log-rank tests showed that the survival time among those cancer patients who under went mass screening increased significantly compared to that of other colorectal cancer patients (P<0.0001). According to the population-based cancer registry in Haining County, age-adjusted incidence and mortality of rectal cancer decreased by 41% and 29% from 1977-1981 to 1992-1996, respectively. Observed cumulative 20-year rectal cancer incidence was 31% lower than the expected in the screened group; the mortality due to rectal cancer was 18% lower than the expected in the screened group.
CONCLUSION: Mass screening for rectal cancer and precursor lesions with protocoscopy in the general population and periodical following-up with routine endoscopy for high-risk patients may decrease both the incidence and mortality of rectal cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12046076      PMCID: PMC4656427          DOI: 10.3748/wjg.v8.i3.488

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

Review 1.  Chemoprevention of colorectal cancer.

Authors:  Karin Gwyn; Frank A Sinicrope
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

2.  American Cancer Society guidelines for the early detection of cancer.

Authors:  Robert A Smith; Vilma Cokkinides; Andrew C von Eschenbach; Bernard Levin; Carmel Cohen; Carolyn D Runowicz; Stephen Sener; Debbie Saslow; Harmon J Eyre
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

Review 3.  Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

Authors:  R A Gupta; R N Dubois
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

4.  Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?

Authors:  C M Ulrich; E Kampman; J Bigler; S M Schwartz; C Chen; R Bostick; L Fosdick; S A Beresford; Y Yasui; J D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-08       Impact factor: 4.254

Review 5.  The advanced adenoma as the primary target of screening.

Authors:  Sidney J Winawer; Ann G Zauber
Journal:  Gastrointest Endosc Clin N Am       Date:  2002-01

6.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

7.  Fecal occult blood testing for colorectal cancer screening: use the finger.

Authors:  C A Burke; L Tadikonda; V Machicao
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

8.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

9.  Carbohydrates and colorectal cancer risk among Chinese in North America.

Authors:  Marilyn J Borugian; Samuel B Sheps; Alice S Whittemore; Anna H Wu; John D Potter; Richard P Gallagher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-02       Impact factor: 4.254

10.  A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.

Authors:  L Bat; A Pines; E Ron; Y Niv; E Arditi; E Shemesh
Journal:  Am J Gastroenterol       Date:  1986-08       Impact factor: 10.864

View more
  14 in total

1.  Barrier-focused intervention to increase colonoscopy attendance among nonadherent high-risk populations.

Authors:  Wen Meng; Xi-Wen Bi; Xiao-Yin Bai; Hua-Feng Pan; Shan-Rong Cai; Qi Zhao; Su-Zhan Zhang
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

2.  Recurrence after transanal endoscopic microsurgery for large rectal adenomas.

Authors:  Marco Ettore Allaix; Alberto Arezzo; Paola Cassoni; Federico Famiglietti; Mario Morino
Journal:  Surg Endosc       Date:  2012-04-05       Impact factor: 4.584

3.  Local excision carcinoma in early stage.

Authors:  Ji-Dong Gao; Yong-Fu Shao; Jian-Jun Bi; Su-Sheng Shi; Jun Liang; Yu-Hua Hu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy.

Authors:  Shu Zheng; Zuo-Xiang Xiao; Yue-Long Pan; Ming-Yong Han; Qi Dong
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

5.  Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang; An-Long Zhu; Lin-Feng Wu; Shu-Yi Qi; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Factors influencing quality of bowel preparation for colonoscopy.

Authors:  Ronald V Romero; Sanjiv Mahadeva
Journal:  World J Gastrointest Endosc       Date:  2013-02-16

7.  Comparative evaluation of immune response after laparoscopical and open total mesorectal excisions with anal sphincter preservation in patients with rectal cancer.

Authors:  Jian-Kun Hu; Zong-Guang Zhou; Zhi-Xin Chen; Lan-Lan Wang; Yong-Yang Yu; Jin Liu; Bo Zhang; Li Li; Ye Shu; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

8.  Effects of depression on parameters of cell-mediated immunity in patients with digestive tract cancers.

Authors:  Ke-Jun Nan; Yong-Chang Wei; Fu-Ling Zhou; Chun-Li Li; Chen-Guang Sui; Ling-Yun Hui; Cheng-Ge Gao
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

Review 9.  Transanal endoscopic surgery in rectal cancer.

Authors:  Xavier Serra-Aracil; Laura Mora-Lopez; Manel Alcantara-Moral; Aleidis Caro-Tarrago; Carlos Javier Gomez-Diaz; Salvador Navarro-Soto
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

10.  Consensus on the Prevention, Screening, Early Diagnosis and Treatment of Colorectal Tumors in China: Chinese Society of Gastroenterology, October 14-15, 2011, Shanghai, China.

Authors:  Jing-Yuan Fang; Shu Zheng; Bo Jiang; Mao-De Lai; Dian-Chun Fang; Ying Han; Qian-Jiu Sheng; Jing-Nan Li; Ying-Xuan Chen; Qin-Yan Gao
Journal:  Gastrointest Tumors       Date:  2014-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.